Literature DB >> 1620237

Difference between aortic and renal vascular reactivity in cyclosporin A treated rats and the effect of cicletanine.

E O Mikkelsen1, S H Poulsen, N C Nyborg, N Korsgaard, J Sehested.   

Abstract

4 Groups of 2 month-old male Wistar rats were treated with a) cyclosporin A (CyA) 30 mg/kg/day alone, b) CyA plus cicletanine (Cic) 60 mg/kg/day, c) vehicle (vegetable oil) 1 ml/100 g rat/day and d) no treatment for 8 weeks. The reactivity of isolated papillary muscle to isoprenaline and Ca2+ was not altered in any of the treated groups. Endothelium-dependent relaxation induced by acetylcholine was inhibited in aorta ring segments from CyA-treated rats as compared to that of control and CyA + Cic-treated rats. The relaxation induced by acetylcholine in rat aortas was similar in all groups in the presence of 10 microM indomethacin. Noradrenaline sensitivity of aortic segments was not affected by any treatments applied. The Ca(2+)-concentration response curves of aorta segments from CyA-treated and CyA + Cic-treated rats were shifted to the right as compared to control rats. In interlobar renal arteries the endothelium-dependent relaxation induced by acetylcholine was not affected by any form of treatment. In renal arteries 10 microM indomethacin increased the maximal relaxation induced by acetylcholine about 50%. In these vessels noradrenaline sensitivity in CyA and CyA + Cic treated rats was higher than in controls. Cocaine, 3 microM, shifted the noradrenaline concentration response curve to the left about 0.4 log units in all renal vessel groups, thus renal vascular smooth muscle sensitivity to noradrenaline was significantly greater in vessels from rats receiving CyA than in vessels from control rats. Administration of CyA induced only slight renal morphological changes. Cic was without effect on CyA induced morphological abnormalities.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1620237     DOI: 10.1007/bf00168698

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Additive inhibitory effect of cyclosporine and verapamil may occur through different mechanisms that may be dependent or independent of the slow calcium channel.

Authors:  M R Weir; R Peppler; D Gomolka; B S Handwerger
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

Review 2.  Cyclosporine A and hypertension.

Authors:  M Schachter
Journal:  J Hypertens       Date:  1988-07       Impact factor: 4.844

3.  Effect of cyclosporine A treatment on vascular reactivity of the rat thoracic aorta.

Authors:  A Rego; R Vargas; M L Foegh; P W Ramwell
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

4.  Lipid mediators in organ transplantation: does cyclosporine accelerate coronary atherosclerosis?

Authors:  M L Hess; A Hastillo; J A Thompson; D J Sansonetti; S Szentpetery; G Barnhart; R R Lower
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

5.  The effect of nifedipine on graft function in renal allograft recipients treated with cyclosporin A.

Authors:  D J Propper; P H Whiting; D A Power; N Edward; G R Catto
Journal:  Clin Nephrol       Date:  1989-08       Impact factor: 0.975

6.  Field stimulation as a means of effecting the graded release of autonomic transmitters in isolated heart muscle.

Authors:  J R Blinks
Journal:  J Pharmacol Exp Ther       Date:  1966-02       Impact factor: 4.030

7.  Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function.

Authors:  H Dieperink; P P Leyssac; H Starklint; K A Jørgensen; E Kemp
Journal:  Eur J Clin Invest       Date:  1986-12       Impact factor: 4.686

8.  Effects of nitrendipine on blood pressure and blood ciclosporin A level in patients with posttransplant hypertension.

Authors:  M S Copur; I Tasdemir; C Turgan; U Yasavul; S Caglar
Journal:  Nephron       Date:  1989       Impact factor: 2.847

9.  Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function.

Authors:  J English; A Evan; D C Houghton; W M Bennett
Journal:  Transplantation       Date:  1987-07       Impact factor: 4.939

10.  A patch-clamp study of the effects of cicletanine on whole-cell calcium current in ventricular myocytes.

Authors:  M P Gisbert; P F Mery; R Fischmeister
Journal:  Drugs Exp Clin Res       Date:  1988
View more
  3 in total

1.  Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment.

Authors:  F Cottet-Maire; P V Avdonin; E Roulet; T M Buetler; N Mermod; U T Ruegg
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

2.  Vascular mechanisms of cyclosporin-induced hypertension in the rat.

Authors:  J B Roullet; H Xue; D A McCarron; S Holcomb; W M Bennett
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  Comparison of in vitro effects of cicletanine, its enantiomers and major metabolite on rat thoracic aorta.

Authors:  E O Mikkelsen; J Sehested; S H Poulsen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.